Drugs / Neosporin
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | NEOSPORIN | — | 1968-07-03 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02138994 Comparator | Jul 2014 → Mar 2016 | chronic ulcer of skin | Next Science TM | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neosporin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02138994 ↗ |
| Route | Topical | “Daily direct application to the wound” NCT02138994 ↗ |